Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Hangzhou Tigermed Consulting Co., Ltd. Class H (3347) Stock Price & Analysis

4 Followers

3347 Stock Chart & Stats

HK$38.56-HK$0.38(-0.98%)
At close: 4:00 PM GMT+8
HK$40HK$45Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
HKD 37.20 - HKD 38.98
52-Week Range
HKD 28.12 - HKD 57.00
Previous Close
HKD 38.94
Volume
N/A
Average Volume (3M)
1.09M
Market Cap
HKD 43.65B
Enterprise Value
HKD 43.47B
Total Cash (Recent Filing)
HKD 2.12B
Total Debt (Recent Filing)
HKD 2.10B
Price to Earnings (P/E)
―
Beta
1.01
Next Earnings
Mar 29, 2027 (Est.)
EPS Estimate
0.6
Last Dividend Ex-Date
Jun 18, 2026
Dividend Yield
0.38%

Bulls Say, Bears Say

Bulls Say

Low Leverage

Tigermed’s low leverage and sizable equity base provide financial flexibility through changing business conditions. Limited debt obligations should reduce balance-sheet strain, preserve capacity to fund operations, and support investment in clinical research capabilities over the next several quarters.

Positive Free Cash Flow

Positive free cash flow despite a reported net loss indicates that the core business is still generating meaningful cash internally. This supports liquidity, ongoing investment, and resilience, while reducing reliance on external financing during the next two to six months.

Operating Profitability

The company retains positive operating and EBITDA margins while revenue continues to grow modestly. This suggests the underlying service platform remains economically viable, even though below-the-line results weakened, and provides a base for recovery if execution and business mix improve.

Bears Say

TTM Net Loss

The shift from healthy annual profitability to a TTM net loss is a material deterioration in earnings quality. Sustained losses can weaken internal funding capacity, reduce returns to shareholders, and make future performance more dependent on restoring profitability across the business.

Gross Margin Compression

The multi-year decline in gross margin points to reduced pricing power or a less favorable service mix, rather than a single-period earnings fluctuation. If persistent, weaker gross economics could limit operating leverage and make revenue growth less valuable to shareholders.

Uneven Cash Conversion

Although cash generation remains positive, its recent decline and uneven multi-year pattern indicate that cash generation is not consistently scaling with reported earnings. Weaker conversion can constrain reinvestment flexibility and reduce the durability of the company’s financial resilience.

Hangzhou Tigermed Consulting Co., Ltd. Class H News

3347 FAQ

What was Hangzhou Tigermed Consulting Co., Ltd. Class H’s price range in the past 12 months?
Hangzhou Tigermed Consulting Co., Ltd. Class H lowest stock price was HK$28.12 and its highest was HK$57.00 in the past 12 months.
What is Hangzhou Tigermed Consulting Co., Ltd. Class H’s market cap?
Hangzhou Tigermed Consulting Co., Ltd. Class H’s market cap is HK$43.65B.
When is Hangzhou Tigermed Consulting Co., Ltd. Class H’s upcoming earnings report date?
Hangzhou Tigermed Consulting Co., Ltd. Class H’s next earnings report is estimated for Mar 29, 2027 (not yet confirmed), which is in 137 days.
How were Hangzhou Tigermed Consulting Co., Ltd. Class H’s earnings last quarter?
Hangzhou Tigermed Consulting Co., Ltd. Class H released its earnings results on Oct 29, 2026. The company reported HK$0.2 earnings per share for the quarter, missing the consensus estimate of HK$0.364 by -HK$0.164.
Is Hangzhou Tigermed Consulting Co., Ltd. Class H overvalued?
According to Wall Street analysts Hangzhou Tigermed Consulting Co., Ltd. Class H’s price is currently Undervalued.
Does Hangzhou Tigermed Consulting Co., Ltd. Class H pay dividends?
Hangzhou Tigermed Consulting Co., Ltd. Class H pays an annual dividend of HK$0.145 which represents an annual dividend yield of 0.38%. See more information on Hangzhou Tigermed Consulting Co., Ltd. Class H dividends here
What is Hangzhou Tigermed Consulting Co., Ltd. Class H’s EPS estimate?
Hangzhou Tigermed Consulting Co., Ltd. Class H’s EPS estimate is 0.60.
How many shares outstanding does Hangzhou Tigermed Consulting Co., Ltd. Class H have?
Hangzhou Tigermed Consulting Co., Ltd. Class H has 123,124,800 shares outstanding.
What happened to Hangzhou Tigermed Consulting Co., Ltd. Class H’s price movement after its last earnings report?
Hangzhou Tigermed Consulting Co., Ltd. Class H reported an EPS of HK$0.2 in its last earnings report, missing expectations of HK$0.364. Following the earnings report the stock price went down -1.605%.
Which hedge fund is a major shareholder of Hangzhou Tigermed Consulting Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:3347
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology